Suppr超能文献

内淋巴分流术治疗梅尼埃病的疗效:与鼓室内庆大霉素治疗眩晕控制和听力损失的比较。

Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.

机构信息

House Ear Institute, University of Southern California, Los Angeles, California 90057, USA.

出版信息

Otol Neurotol. 2010 Jun;31(4):649-55. doi: 10.1097/MAO.0b013e3181dd13ac.

Abstract

OBJECTIVE

To compare proportions of the combined outcome of vertigo control and hearing preservation between intratympanic gentamicin injections and endolymphatic sac shunt surgery for intractable vertigo in Ménière's disease patients.

STUDY DESIGN

Analysis of published data and retrospective review.

SETTING

Tertiary otologic referral center.

PATIENTS

Patients with Ménière's disease who had failed medical management: 183 surgical patients (shunt group) and 203 patients obtained from 6 published gentamicin treatment studies (gentamicin group). Cases were included if hearing and vertigo data were available before and after treatment with no previous surgical or injection treatment. Average patient age ranged from 45 to 59 years across studies. Gentamicin studies had nearly equal female to male subjects, whereas the shunt group was 60% female.

INTERVENTIONS

Endolymphatic sac shunt surgery or intratympanic gentamicin treatment of differing doses and injection schedules.

MAIN OUTCOME MEASURE

Proportion of patients with best combined vertigo control/hearing preservation. Hearing preservation is 10 dB or less increase in pure-tone average. Outcomes were categorized as follows: complete vertigo control/hearing preservation (best), complete vertigo control/hearing loss, incomplete vertigo control/hearing preservation, and incomplete vertigo control/hearing loss (worst).

RESULTS

The shunt group showed a significantly higher percentage of the best outcome (62%) than the gentamicin group (56%, p <or= 0.003), as well as a higher rate of complete vertigo control (86% versus 71%; p <or= 0.001).

CONCLUSION

A higher percentage of patients undergoing shunt surgery attained complete vertigo control/hearing preservation relative to intratympanic gentamicin. There continues to be significant variability in gentamicin outcomes, suggesting that the technique requires additional refinement before consistently producing good outcomes.

摘要

目的

比较梅尼埃病患者接受鼓室内庆大霉素注射与内淋巴囊分流术治疗难治性眩晕后眩晕控制和听力保留的综合结果比例。

研究设计

已发表数据的分析和回顾性研究。

设置

三级耳科转诊中心。

患者

经药物治疗失败的梅尼埃病患者:183 例手术患者(分流组)和 203 例来自 6 项已发表的庆大霉素治疗研究的患者(庆大霉素组)。如果治疗前后有听力和眩晕数据且无先前手术或注射治疗,则纳入病例。各研究中患者的平均年龄在 45 至 59 岁之间。庆大霉素研究中女性与男性患者比例几乎相等,而分流组中女性占 60%。

干预措施

内淋巴囊分流术或不同剂量和注射方案的鼓室内庆大霉素治疗。

主要观察指标

最佳综合眩晕控制/听力保留患者的比例。听力保留是指纯音平均听力提高 10 dB 或以下。结果分为以下几类:最佳的完全眩晕控制/听力保留(最佳)、完全眩晕控制/听力丧失、不完全眩晕控制/听力保留和不完全眩晕控制/听力丧失(最差)。

结果

分流组的最佳结果(62%)比例显著高于庆大霉素组(56%,p < 0.003),且完全眩晕控制率也更高(86%对 71%;p < 0.001)。

结论

与鼓室内庆大霉素相比,接受分流手术的患者有更高比例达到完全眩晕控制/听力保留。庆大霉素的结果仍然存在显著差异,这表明该技术需要进一步改进,才能始终产生良好的结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验